Titan Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

8.26

8.26

8.26

8.26

8.26

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

97.83

77.98

57.56

29.55

23.40

Loan funds

Secured loans

7.00

5.80

7.54

16.89

20.85

Unsecured loans

-

-

-

-

-

Total

113.09

92.04

73.36

54.70

52.51

Uses of funds

Fixed assets

Gross block

35.89

47.89

38.34

34.44

33.37

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

-

12.90

11.30

9.20

7.47

Net block

35.89

34.99

27.04

25.24

25.90

Capital work-in-progress

13.29

3.63

0.27

-

-

Investments

11.59

4.03

1.27

1.27

1.27

Net current assets

Current assets, loans & advances

69.92

64.91

57.59

38.68

32.64

Less : current liabilities & provisions

17.61

15.52

12.81

10.50

7.30

Total net current assets

52.32

49.39

44.77

28.19

25.33

Miscellaneous expenses not written

-

-

-

-

-

Total

113.09

92.04

73.36

54.70

52.51

Notes:

Book value of unquoted investments

11.59

4.03

1.27

1.27

1.27

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

1.13

3.20

0.77

-

-

Number of equity sharesoutstanding (Lacs)

82.64

82.64

82.64

82.64

82.64